---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-032138"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2023-09-08T23:59:59+00:00"
generated_at: "2026-06-10T22:02:05.486822+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MyMD grants 1M options to President/CMO; salary raised to $500k

## Summary
- Options to purchase 1,000,000 shares at $0.81 per share, vesting on clinical milestones over 12 months.
- Annual base salary set at $500,000 retroactive to Jan 1, 2023, under amended employment agreement.
- Dr. Chapman must devote majority of efforts to the Company.
- Options granted under the 2021 Equity Incentive Plan approved by compensation committee.

## SEC filing metadata
- accession: 0001493152-23-032138
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2023-09-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315223032138/0001493152-23-032138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315223032138/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-032138
- JSON: https://secwatch.observer/filing/0001493152-23-032138.json
- Plain text: https://secwatch.observer/filing/0001493152-23-032138.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.